Skip to main content

Table 1 Characteristics of the 11 included studies

From: Short-term effects of intragastric balloon in association with conservative therapy on weight loss: a meta-analysis

References

Country

Sample size, n

Age, years

Men, %

BMI, kg/m2

Intervention therapy

Comparison therapy

Time point, months

Lindor et al. (1987) [15]

USA

22

25–51

9

>30

IGB

Sham

3

Ramhamadany et al. (1989) [16]

England

24

NA

0

41

IGB + BM

Sham + BM

3

Geliebter et al. (1991) [17]

USA

86

NA

19

>40

IGB ± BM

BM/NT

3

Martinez-Brocca et al. (2007) [18]

Spain

22

36 ± 10

23

50.4 ± 7.8

IGB

Sham

4

Konopko-Zubrzycka et al. (2009) [19]

Poland

36

42 ± 12

47

47.2 ± 5.5

IGB + BM

BM

6

Farina et al. (2012) [20]

Italy

50

35 ± 1

22

41.8 ± 0.8

IGB + BM + PT

BM + PT

12

Lee et al. (2012) [21]

Singapore

21

21–65

61

31.5 ± 4.5

IGB + BM

Sham + BM

6

Fuller et al. (2013) [22]

Australia

66

46 ± 9

33

36.4 ± 2.6

IGB + BM

BM

6

Ponce et al. (2013) [23]

USA

30

41 ± 9

13

35.0 ± 2.6

IGB + BM

BM

6

Mathus-Vliegen and Eichenberger (2014) [24]

The Netherlands

40

42 ± 11

10

43.1 ± 6.3

IGB

Sham

3

Mohammed et al. (2014) [25]

Egypt

128

44 ± 9

58

47.7 ± 1.1

IGB + BM

BM

6

  1. BMI body mass index, IGB intragastric balloon, NA not available, BM behavioral modification, NT no treatment, PT pharmacotherapy.